Stock listing

Traws Pharma, Inc.

Selected listing: A40PJ7 · LS · EUR · DE

Traws Pharma, Inc. (Lang & Schwarz: A40PJ7), Health Technology. Latest release Aug 14, 2026: Traws Pharma Reports Q2 2026 Financial Results and Provides…

A40PJ7:LSEURDEUpdated October 2, 2026

Ticker: Lang & Schwarz: A40PJ7
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: Lang & Schwarz
Currency: EUR

About Traws Pharma, Inc.

Traws Pharma, Inc. (TRAW) is listed on 6ix with investor news, events, company updates, and market data in one place. Follow the company page to track new releases, upcoming presentations, and the latest information available on 6ix.

Latest news from Traws Pharma, Inc.

Traws Pharma Reports Q2 2026 Financial Results and Provides Business Highlights

August 14, 2026

Traws Pharma Provides Updated Guidance on Influenza Prophylaxis Program

June 21, 2026

Traws Pharma Provides Regulatory Update on Influenza Program

June 12, 2026

Traws Pharma Announces Antiviral Program Targeting Ongoing Hantavirus and Ebola Virus Disease Outbreaks

May 26, 2026

Traws Pharma Provides Business Highlights and Reports Q1 2026 Financial Results

May 15, 2026

All Traws Pharma, Inc. news →

Events

Replays

Traws Pharma, Inc. (TRAW) Q4 2025 Earnings Call
Wed, Apr 15, 2026 · 04:30 PM ET
Watch
Traws Pharma, Inc. (TRAW) Q2 2025 Earnings Call
Thu, Aug 14, 2025 · 08:30 AM ET
Watch

Research Traws Pharma, Inc.

Traws Pharma, Inc. company profile

View the public company page for Traws Pharma, Inc. on 6ix.

Traws Pharma, Inc. news

Read company news and market updates connected to Traws Pharma, Inc..

Traws Pharma, Inc. investor events

Find investor webinars, events, and replay context for Traws Pharma, Inc..